Consistent with the results of the TCGA data analysis, there were more patients (83%) with high LRRN4 expression in CRC than in normal colorectal tissue (39%) (Fig. 2D,  p < 0.001). This evidence concerns the gene LRRN4 and colorectal carcinoma.